| Literature DB >> 31178852 |
Alexey S Vasilchenko1, Eugene A Rogozhin2,3.
Abstract
Antimicrobials, and particularly antimicrobial peptides (AMPs), have been thoroughly studied due to their therapeutic potential. The research on their exact mode of action on bacterial cells, especially at under sublethal concentrations, has resulted in a better understanding of the unpredictable nature of bacterial behavior under stress conditions. In this review, we were aiming to gather the wide yet still under-investigated knowledge about various AMPs and their subinhibition effects on cellular and molecular levels. We describe how AMP action is non-linear and unpredictable, also showing that exposure to AMP can lead to antimicrobial resistance via triggering various regulatory systems. Being one of the most known types of antimicrobials, bacteriocins have dual action and can also be utilized by microorganisms as signaling molecules at naturally achievable sub-inhibitory concentrations. The unpredictable nature of AMP action and the pathogenic response triggered by them remains an area of knowledge that requires further investigation.Entities:
Keywords: AMP; antimicrobial peptides; factor of pathogenicity; sub-inhibitory effects; virulence
Year: 2019 PMID: 31178852 PMCID: PMC6543913 DOI: 10.3389/fmicb.2019.01160
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
The physico-chemical properties of antimicrobial peptides described in the review.
| Peptide | Mol. weight, Da1 | Type of structure | Charge2 | μHrel2 | GRAVY1 | The sources of the structural data |
|---|---|---|---|---|---|---|
| LL-37 | 4490.6 | Alpha-helix conformation | +6 | 0.499 | −0.72 | |
| Cecropin A | 4004.82 | Alpha-helix conformation | +6 | 0.202 | −0.07 | |
| Indolicidin | 1700 | Random coil | +4 | 0.190 | −1.07 | |
| Fallaxin analog FL9 | 2717 | Alpha-helix | +2 | 0.275 | 0.51 | |
| C18G | 2043 | Alpha-helix | +7 | 0.604 | −0.19 | |
| α-defensin HNP-1 | 3448 | β-strand, β-turn | +3 | 0.028 | 0.30 | |
| β-defensin hBD-1 | 3934 | Alpha-helix and triple-stranded antiparallel β-sheet | +4 | 0.348 | −0.27 | |
| β-defensin hBD-2 | 3885.9 | Alpha-helix and triple-stranded antiparallel β-sheet | +6 | 0.246 | −0.10 | |
| Bovicin HC5 | 3525 | +2 | 0.163 | 0.28 | ||
| Subtilosin A | 3425 | Cysteine sulfur to α-carbon bridges | −2.2 | 0.08 | 0.69 | |
| Plantaricin A | 2683 | Alpha-helix conformation | +5 | 0.321 | −0.24 | |
| Subtilin | 3465 | Fivefold-stranded antiparallel β-sheet and alpha-helices | +2 | 0.151 | 0.19 | |
| Nisin Z | 3475 | Alpha-helices and β-turn | +3 | 0.084 | 0.41 | |
| Polymyxin B | 1203.50 | Cyclic | +5 | ND | ND | |
| Colistin | 1156.0 | Cyclic | +5 | ND | ND | |
| Hemoglobin-derived Hbg-1 | 2495 | Random coil | +1 | 0.053 | −0.56 | |
| Hemoglobin-derived Hbg-2 | 2495 | Random coil | +1 | 0.220 | −0.56 | |
| Dipeptides cyclo( | 245.35 | ND | ND | ND | ND |
The mode of action and sub-inhibitory effects of peptides described in the review.
| Peptide | The cell’s targets | Negative sub-MIC effects∗ | Positive sub-MIC effects∗ | References |
|---|---|---|---|---|
| LL-37 | Membranes permeabilization; direct DNA binding | Promote mucoidy phenotype in Gr-bacteria; overproduction of virulence factors; promote resistance to antimicrobials | Inhibites biofilm formation | |
| Cecropin A | Membranes permeabilization | Unknown | Unknown | |
| Indolicidin | Membranes permeabilization; direct DNA binding | Promote resistance to antimicrobials | Prevent biofilm development of MRSA | |
| Fallaxin analog FL9 | Membranes permeabilization; direct DNA binding | Increase production of α-haemolysin | Unknown | |
| C18G | Membranes permeabilization | Increased expression of the virulence factor of | Unknown | |
| α-defensin HNP-1 | Membranes permeabilization; lipid II binding; target the ExPortal of | Unknown | inhibition of secretion of SpeB cysteine protease and the streptolysin O | |
| β-defensin hBD-2 | Membranes permeabilization | Unknown | Regulatory of gut homeostasis | |
| Bovicin HC5 | Membranes permeabilization | Unknown | Prevents biofilm formation of | |
| Subtilosin | Membranes permeabilization | Unknown | Prevents biofilm formation of Gram-negative bacteria | |
| Plantaricin A | Membranes permeabilization at high ( | Unknown | Involved in the formation of a sustainable animal microbiome | |
| Nisin | Membranes permeabilization; inhibites peptidoglycan sintesis; pheromone | Unknown | Inhibites bacterial biofilm formation | |
| Polymyxin B | Membranes permeabilization | Promote resistance to antimicrobials | Inhibites of secretion of SpeB cysteine protease and the streptolysin O | |
| Colistin | Membranes permeabilization | Resistance; promote biofilm formation; pyocyanin production | ||
| Hemoglobin-derived peptides (Hbg-1, 2 and other) | Membranes permeabilization | Promote | Inhibites production of TSS toxin-1, enterotoxin C, α, δ hemolysin of | |
| Dipeptides cyclo( | Unknown | Unknown | Inhibites production of TSS toxin-1 |
FIGURE 1Diagram showing the main receptors of antimicrobial peptides and the relationship between them. The mechanisms of signal transmission from the activated receptor to the corresponding genes are shown. Antimicrobial peptides is capable to direct (PhoQ, PmrAB, and other) or indirect (RcsF) activation of the histidine kinase sensors, which led to regulation of activity of appropriated genes. At the same time, the expression of some genes can simultaneously be under the positive and/or negative regulation of different TCS. For example, the effect of polymyxin B on the bacterial outer membrane can activates the RcsF sensors, what leads to inhibition of expression of virulence genes in srfABC operon. Interestingly, the same operon is activated by another TSC PmrAB, for which “Peptide Sensing” was revealed (for example, for LL-37).
FIGURE 2Demonstration of the signaling role of bacteriocins in the formation of a sustainable mammalian gut microbiome. The Lactobacillus strain producing plantaricin A triggers the expression of genes and the production of metabolites that enhance the colonizing ability (adhesion and biofilm formation) of another Lactobacillus strain. The occupied econish is no longer available for pathogenic and conditionally pathogenic microorganisms (S. aureus and S. typhimurium). In addition, certain (PlnC) activators of bacteriocin production (Plantaricin EF, for example) and some component of the agr QS-system (AgrB) are launched in susceptible to PlnA Lactobacilli cells, which has a certain antagonistic effect on the competitor species. Also plantaricin A triggers the production of human β-defensin 2 of the intestinal epithelium, which potentially has an antagonistic effect on a number of pathogenic and conditionally pathogenic microorganisms.